You can view the research column published every month by SMC Laboratories.
2025.02.04
Latest IBD Models Materials
We are pleased to introduce the latest materials showcasing our DSS induced IBD model, designed to provide val…
READ MORE
2025.02.04
Preclinical COPD research with positive controls
We would like to introduce a positive control (Roflumilast) in a drug efficacy evaluation study using PPE-indu…
READ MORE
2025.02.03
TAA model: Acute liver failure model
We would like to introduce an acute liver failure (ALF), thioacetamide (TAA)-induced ALF model. For thi…
READ MORE
2025.02.03
The comparison of NASH-HCC and other HCC models
Today, we present the third part of the comparison table on liver cancer models. Liver cancer is the si…
READ MORE
2025.02.03
The STAM model as a model of liver fibrosis
Today, we present the comparison table on fibrosis models of the liver. Liver fibrosis is defined as ex…
READ MORE
2025.02.03
Silica-induced pulmonary fibrosis model
We would like to introduce you to a Silica-induced pulmonary fibrosis model. This model is suitable for you if…
READ MORE
2025.02.03
In Vitro Assay Service for Fibrosis Evaluation
We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation. &nbs…
READ MORE
2025.02.03
STAM mouse | Adiponectin-derived peptide study to inhibit MASH and fibrosis progression
Today, we would like to introduce an example of a proof-of-concept study of adiponectin-derived peptide ALY688…
READ MORE
2025.02.03
Lung functional marker in IPF model
We would like to introduce a non-invasive biomarkers for Idiopathic Pulmonary Fibrosis (IPF) disease models. &…
READ MORE
2025.02.03
Drug efficacy studies in NASH mouse model
Today, we would like to introduce a paper published by our client using our non-alcoholic steatohepatitis (NAS…
READ MORE
